 |
|
|
|
|
|
|
 |
|
 |
|
|||
 |
|
|||||
 |
 |
 |
 |
|
||
 |
|
|||||
|
||||||
 |
|
|||||
 
|
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
|
|
 
|
|
Press Releases ---------------------------------------------------------------- FOR IMMEDIATE RELEASE
IRIS TO RELEASE SECOND QUARTER FINANCIAL RESULTS AND HOST CONFERENCE CALL ON WEDNESDAY, AUG. 2, 2006 CHATSWORTH, Calif., July 11, 2006 — IRIS International, Inc. (NASDAQ: IRIS) will hold a conference call with members of the investment community on Wednesday, August 2, at 4:30 p.m. Eastern time. César García, President and Chief Executive Officer, and Donald C. Mueller, Chief Financial Officer, will be reviewing the Company's financial results for the second quarter ended June 30, 2006, which will be announced at the close of the market. To participate, dial 1-800-289-0528 approximately 10 minutes before the conference call is scheduled to begin. Hold for the operator and reference the IRIS International conference call. International callers should dial 913-981-5522. The conference call may also be accessed by means of a live audio Web cast on the Company's Web site at www.proiris.com, or at www.vcall.com, the Web cast service provider. The conference audio cast will also be available for replay on both Web sites for 30 days from the date of the broadcast. For anyone who is unable to participate in the conference, access to a recording will be available for seven days following the call. Dial 1-888-203-1112 to access playback. For international callers, dial 719-457-0820. The pass code I.D. is 4350212. The Company IRIS International, Inc. (http://www.proiris.com), based in Chatsworth, Calif., is a leader in automated urinalysis technology with systems in major medical institutions throughout the world. The Company's Sample Processing business unit (formerly the StatSpin® subsidiary) (www.statspin.com), based in Westwood, Mass., manufactures innovative centrifuges and blood analysis products. Advanced Digital Imaging Research, LLC (ADIR) (www.adires.com), based near Houston, Texas, is the Company's imaging research and development subsidiary. The IRIS Molecular Diagnostics (IMD) Subsidiary develops innovative ultra-sensitive diagnostics and sample processing products with applications in the urinalysis, oncology and infectious disease markets. |
